Global Novel Coronavirus Inactivated Vaccine Production, Demand and Key Producers, 2022-2028
This report studies the global Novel Coronavirus Inactivated Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Novel Coronavirus Inactivated Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Novel Coronavirus Inactivated Vaccine that contribute to its increasing demand across many markets.
The global Novel Coronavirus Inactivated Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Novel Coronavirus Inactivated Vaccine total production and demand, 2017-2028, (K Units)
Global Novel Coronavirus Inactivated Vaccine total production value, 2017-2028, (USD Million)
Global Novel Coronavirus Inactivated Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Novel Coronavirus Inactivated Vaccine consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Novel Coronavirus Inactivated Vaccine domestic production, consumption, key domestic manufacturers and share
Global Novel Coronavirus Inactivated Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Novel Coronavirus Inactivated Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Novel Coronavirus Inactivated Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Novel Coronavirus Inactivated Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Novel Coronavirus Inactivated Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Novel Coronavirus Inactivated Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Novel Coronavirus Inactivated Vaccine Market, By Region:
1. How big is the global Novel Coronavirus Inactivated Vaccine market?
2. What is the demand of the global Novel Coronavirus Inactivated Vaccine market?
3. What is the year over year growth of the global Novel Coronavirus Inactivated Vaccine market?
4. What is the production and production value of the global Novel Coronavirus Inactivated Vaccine market?
5. Who are the key producers in the global Novel Coronavirus Inactivated Vaccine market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Novel Coronavirus Inactivated Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Novel Coronavirus Inactivated Vaccine that contribute to its increasing demand across many markets.
The global Novel Coronavirus Inactivated Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Novel Coronavirus Inactivated Vaccine total production and demand, 2017-2028, (K Units)
Global Novel Coronavirus Inactivated Vaccine total production value, 2017-2028, (USD Million)
Global Novel Coronavirus Inactivated Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Novel Coronavirus Inactivated Vaccine consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Novel Coronavirus Inactivated Vaccine domestic production, consumption, key domestic manufacturers and share
Global Novel Coronavirus Inactivated Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Novel Coronavirus Inactivated Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Novel Coronavirus Inactivated Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Novel Coronavirus Inactivated Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Novel Coronavirus Inactivated Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Novel Coronavirus Inactivated Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Novel Coronavirus Inactivated Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Adult
- Child
- Hospital
- Clinic
- Inovio Pharmaceuticals
- Moderna
- GlaxoSmithKine
- Pfizer
- Johnson&Johnson
- Heat Biologics
- Sanofi
- Beijing Institute of Biological Products Co., Ltd
- Beijing Kexing Zhongwei Biotechnology Co., Ltd
- Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd
- Wuhan Institute of Biological Products Co., Ltd
1. How big is the global Novel Coronavirus Inactivated Vaccine market?
2. What is the demand of the global Novel Coronavirus Inactivated Vaccine market?
3. What is the year over year growth of the global Novel Coronavirus Inactivated Vaccine market?
4. What is the production and production value of the global Novel Coronavirus Inactivated Vaccine market?
5. Who are the key producers in the global Novel Coronavirus Inactivated Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Novel Coronavirus Inactivated Vaccine Introduction
1.2 World Novel Coronavirus Inactivated Vaccine Supply & Forecast
1.2.1 World Novel Coronavirus Inactivated Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Novel Coronavirus Inactivated Vaccine Production (2017-2028)
1.2.3 World Novel Coronavirus Inactivated Vaccine Pricing Trends (2017-2028)
1.3 World Novel Coronavirus Inactivated Vaccine Production by Region
1.3.1 World Novel Coronavirus Inactivated Vaccine Production Value by Region (2017-2028)
1.3.2 World Novel Coronavirus Inactivated Vaccine Production by Region (2017-2028)
1.3.3 World Novel Coronavirus Inactivated Vaccine Average Price by Region (2017-2028)
1.3.4 North America Novel Coronavirus Inactivated Vaccine Production (2017-2028)
1.3.5 Europe Novel Coronavirus Inactivated Vaccine Production (2017-2028)
1.3.6 China Novel Coronavirus Inactivated Vaccine Production (2017-2028)
1.3.7 Japan Novel Coronavirus Inactivated Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Novel Coronavirus Inactivated Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Novel Coronavirus Inactivated Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Novel Coronavirus Inactivated Vaccine Demand (2017-2028)
2.2 World Novel Coronavirus Inactivated Vaccine Consumption by Region
2.2.1 World Novel Coronavirus Inactivated Vaccine Consumption by Region (2017-2022)
2.2.2 World Novel Coronavirus Inactivated Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Novel Coronavirus Inactivated Vaccine Consumption (2017-2028)
2.4 China Novel Coronavirus Inactivated Vaccine Consumption (2017-2028)
2.5 Europe Novel Coronavirus Inactivated Vaccine Consumption (2017-2028)
2.6 Japan Novel Coronavirus Inactivated Vaccine Consumption (2017-2028)
2.7 South Korea Novel Coronavirus Inactivated Vaccine Consumption (2017-2028)
2.8 ASEAN Novel Coronavirus Inactivated Vaccine Consumption (2017-2028)
2.9 India Novel Coronavirus Inactivated Vaccine Consumption (2017-2028)
3 WORLD NOVEL CORONAVIRUS INACTIVATED VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Novel Coronavirus Inactivated Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Novel Coronavirus Inactivated Vaccine Production by Manufacturer (2017-2022)
3.3 World Novel Coronavirus Inactivated Vaccine Average Price by Manufacturer (2017-2022)
3.4 Novel Coronavirus Inactivated Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Novel Coronavirus Inactivated Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Novel Coronavirus Inactivated Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Novel Coronavirus Inactivated Vaccine in 2021
3.6 Novel Coronavirus Inactivated Vaccine Market: Overall Company Footprint Analysis
3.6.1 Novel Coronavirus Inactivated Vaccine Market: Region Footprint
3.6.2 Novel Coronavirus Inactivated Vaccine Market: Company Product Type Footprint
3.6.3 Novel Coronavirus Inactivated Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Novel Coronavirus Inactivated Vaccine Production Value Comparison
4.1.1 United States VS China: Novel Coronavirus Inactivated Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Novel Coronavirus Inactivated Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Novel Coronavirus Inactivated Vaccine Production Comparison
4.2.1 United States VS China: Novel Coronavirus Inactivated Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Novel Coronavirus Inactivated Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Novel Coronavirus Inactivated Vaccine Consumption Comparison
4.3.1 United States VS China: Novel Coronavirus Inactivated Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Novel Coronavirus Inactivated Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Novel Coronavirus Inactivated Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Novel Coronavirus Inactivated Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Novel Coronavirus Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Novel Coronavirus Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Novel Coronavirus Inactivated Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Novel Coronavirus Inactivated Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Novel Coronavirus Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Novel Coronavirus Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Novel Coronavirus Inactivated Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Novel Coronavirus Inactivated Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Novel Coronavirus Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Novel Coronavirus Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Novel Coronavirus Inactivated Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Adult
5.2.2 Child
5.3 Market Segment by Type
5.3.1 World Novel Coronavirus Inactivated Vaccine Production by Type (2017-2028)
5.3.2 World Novel Coronavirus Inactivated Vaccine Production Value by Type (2017-2028)
5.3.3 World Novel Coronavirus Inactivated Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Novel Coronavirus Inactivated Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Novel Coronavirus Inactivated Vaccine Production by Application (2017-2028)
6.3.2 World Novel Coronavirus Inactivated Vaccine Production Value by Application (2017-2028)
6.3.3 World Novel Coronavirus Inactivated Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Inovio Pharmaceuticals
7.1.1 Inovio Pharmaceuticals Details
7.1.2 Inovio Pharmaceuticals Major Business
7.1.3 Inovio Pharmaceuticals Novel Coronavirus Inactivated Vaccine Product and Services
7.1.4 Inovio Pharmaceuticals Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Inovio Pharmaceuticals Recent Developments/Updates
7.1.6 Inovio Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Moderna
7.2.1 Moderna Details
7.2.2 Moderna Major Business
7.2.3 Moderna Novel Coronavirus Inactivated Vaccine Product and Services
7.2.4 Moderna Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Moderna Recent Developments/Updates
7.2.6 Moderna Competitive Strengths & Weaknesses
7.3 GlaxoSmithKine
7.3.1 GlaxoSmithKine Details
7.3.2 GlaxoSmithKine Major Business
7.3.3 GlaxoSmithKine Novel Coronavirus Inactivated Vaccine Product and Services
7.3.4 GlaxoSmithKine Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 GlaxoSmithKine Recent Developments/Updates
7.3.6 GlaxoSmithKine Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Novel Coronavirus Inactivated Vaccine Product and Services
7.4.4 Pfizer Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Johnson&Johnson
7.5.1 Johnson&Johnson Details
7.5.2 Johnson&Johnson Major Business
7.5.3 Johnson&Johnson Novel Coronavirus Inactivated Vaccine Product and Services
7.5.4 Johnson&Johnson Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Johnson&Johnson Recent Developments/Updates
7.5.6 Johnson&Johnson Competitive Strengths & Weaknesses
7.6 Heat Biologics
7.6.1 Heat Biologics Details
7.6.2 Heat Biologics Major Business
7.6.3 Heat Biologics Novel Coronavirus Inactivated Vaccine Product and Services
7.6.4 Heat Biologics Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Heat Biologics Recent Developments/Updates
7.6.6 Heat Biologics Competitive Strengths & Weaknesses
7.7 Sanofi
7.7.1 Sanofi Details
7.7.2 Sanofi Major Business
7.7.3 Sanofi Novel Coronavirus Inactivated Vaccine Product and Services
7.7.4 Sanofi Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Sanofi Recent Developments/Updates
7.7.6 Sanofi Competitive Strengths & Weaknesses
7.8 Beijing Institute of Biological Products Co., Ltd
7.8.1 Beijing Institute of Biological Products Co., Ltd Details
7.8.2 Beijing Institute of Biological Products Co., Ltd Major Business
7.8.3 Beijing Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
7.8.4 Beijing Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
7.8.6 Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.9 Beijing Kexing Zhongwei Biotechnology Co., Ltd
7.9.1 Beijing Kexing Zhongwei Biotechnology Co., Ltd Details
7.9.2 Beijing Kexing Zhongwei Biotechnology Co., Ltd Major Business
7.9.3 Beijing Kexing Zhongwei Biotechnology Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
7.9.4 Beijing Kexing Zhongwei Biotechnology Co., Ltd Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Beijing Kexing Zhongwei Biotechnology Co., Ltd Recent Developments/Updates
7.9.6 Beijing Kexing Zhongwei Biotechnology Co., Ltd Competitive Strengths & Weaknesses
7.10 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd
7.10.1 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Details
7.10.2 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Major Business
7.10.3 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
7.10.4 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Recent Developments/Updates
7.10.6 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.11 Wuhan Institute of Biological Products Co., Ltd
7.11.1 Wuhan Institute of Biological Products Co., Ltd Details
7.11.2 Wuhan Institute of Biological Products Co., Ltd Major Business
7.11.3 Wuhan Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
7.11.4 Wuhan Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Wuhan Institute of Biological Products Co., Ltd Recent Developments/Updates
7.11.6 Wuhan Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Novel Coronavirus Inactivated Vaccine and Key Manufacturers
8.2 Novel Coronavirus Inactivated Vaccine Manufacturing Costs
8.3 Novel Coronavirus Inactivated Vaccine Production Process
8.4 Novel Coronavirus Inactivated Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Novel Coronavirus Inactivated Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Novel Coronavirus Inactivated Vaccine Typical Distributors
9.3 Novel Coronavirus Inactivated Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Novel Coronavirus Inactivated Vaccine Introduction
1.2 World Novel Coronavirus Inactivated Vaccine Supply & Forecast
1.2.1 World Novel Coronavirus Inactivated Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Novel Coronavirus Inactivated Vaccine Production (2017-2028)
1.2.3 World Novel Coronavirus Inactivated Vaccine Pricing Trends (2017-2028)
1.3 World Novel Coronavirus Inactivated Vaccine Production by Region
1.3.1 World Novel Coronavirus Inactivated Vaccine Production Value by Region (2017-2028)
1.3.2 World Novel Coronavirus Inactivated Vaccine Production by Region (2017-2028)
1.3.3 World Novel Coronavirus Inactivated Vaccine Average Price by Region (2017-2028)
1.3.4 North America Novel Coronavirus Inactivated Vaccine Production (2017-2028)
1.3.5 Europe Novel Coronavirus Inactivated Vaccine Production (2017-2028)
1.3.6 China Novel Coronavirus Inactivated Vaccine Production (2017-2028)
1.3.7 Japan Novel Coronavirus Inactivated Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Novel Coronavirus Inactivated Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Novel Coronavirus Inactivated Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Novel Coronavirus Inactivated Vaccine Demand (2017-2028)
2.2 World Novel Coronavirus Inactivated Vaccine Consumption by Region
2.2.1 World Novel Coronavirus Inactivated Vaccine Consumption by Region (2017-2022)
2.2.2 World Novel Coronavirus Inactivated Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Novel Coronavirus Inactivated Vaccine Consumption (2017-2028)
2.4 China Novel Coronavirus Inactivated Vaccine Consumption (2017-2028)
2.5 Europe Novel Coronavirus Inactivated Vaccine Consumption (2017-2028)
2.6 Japan Novel Coronavirus Inactivated Vaccine Consumption (2017-2028)
2.7 South Korea Novel Coronavirus Inactivated Vaccine Consumption (2017-2028)
2.8 ASEAN Novel Coronavirus Inactivated Vaccine Consumption (2017-2028)
2.9 India Novel Coronavirus Inactivated Vaccine Consumption (2017-2028)
3 WORLD NOVEL CORONAVIRUS INACTIVATED VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Novel Coronavirus Inactivated Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Novel Coronavirus Inactivated Vaccine Production by Manufacturer (2017-2022)
3.3 World Novel Coronavirus Inactivated Vaccine Average Price by Manufacturer (2017-2022)
3.4 Novel Coronavirus Inactivated Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Novel Coronavirus Inactivated Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Novel Coronavirus Inactivated Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Novel Coronavirus Inactivated Vaccine in 2021
3.6 Novel Coronavirus Inactivated Vaccine Market: Overall Company Footprint Analysis
3.6.1 Novel Coronavirus Inactivated Vaccine Market: Region Footprint
3.6.2 Novel Coronavirus Inactivated Vaccine Market: Company Product Type Footprint
3.6.3 Novel Coronavirus Inactivated Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Novel Coronavirus Inactivated Vaccine Production Value Comparison
4.1.1 United States VS China: Novel Coronavirus Inactivated Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Novel Coronavirus Inactivated Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Novel Coronavirus Inactivated Vaccine Production Comparison
4.2.1 United States VS China: Novel Coronavirus Inactivated Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Novel Coronavirus Inactivated Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Novel Coronavirus Inactivated Vaccine Consumption Comparison
4.3.1 United States VS China: Novel Coronavirus Inactivated Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Novel Coronavirus Inactivated Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Novel Coronavirus Inactivated Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Novel Coronavirus Inactivated Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Novel Coronavirus Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Novel Coronavirus Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Novel Coronavirus Inactivated Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Novel Coronavirus Inactivated Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Novel Coronavirus Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Novel Coronavirus Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Novel Coronavirus Inactivated Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Novel Coronavirus Inactivated Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Novel Coronavirus Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Novel Coronavirus Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Novel Coronavirus Inactivated Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Adult
5.2.2 Child
5.3 Market Segment by Type
5.3.1 World Novel Coronavirus Inactivated Vaccine Production by Type (2017-2028)
5.3.2 World Novel Coronavirus Inactivated Vaccine Production Value by Type (2017-2028)
5.3.3 World Novel Coronavirus Inactivated Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Novel Coronavirus Inactivated Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Novel Coronavirus Inactivated Vaccine Production by Application (2017-2028)
6.3.2 World Novel Coronavirus Inactivated Vaccine Production Value by Application (2017-2028)
6.3.3 World Novel Coronavirus Inactivated Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Inovio Pharmaceuticals
7.1.1 Inovio Pharmaceuticals Details
7.1.2 Inovio Pharmaceuticals Major Business
7.1.3 Inovio Pharmaceuticals Novel Coronavirus Inactivated Vaccine Product and Services
7.1.4 Inovio Pharmaceuticals Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Inovio Pharmaceuticals Recent Developments/Updates
7.1.6 Inovio Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Moderna
7.2.1 Moderna Details
7.2.2 Moderna Major Business
7.2.3 Moderna Novel Coronavirus Inactivated Vaccine Product and Services
7.2.4 Moderna Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Moderna Recent Developments/Updates
7.2.6 Moderna Competitive Strengths & Weaknesses
7.3 GlaxoSmithKine
7.3.1 GlaxoSmithKine Details
7.3.2 GlaxoSmithKine Major Business
7.3.3 GlaxoSmithKine Novel Coronavirus Inactivated Vaccine Product and Services
7.3.4 GlaxoSmithKine Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 GlaxoSmithKine Recent Developments/Updates
7.3.6 GlaxoSmithKine Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Novel Coronavirus Inactivated Vaccine Product and Services
7.4.4 Pfizer Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Johnson&Johnson
7.5.1 Johnson&Johnson Details
7.5.2 Johnson&Johnson Major Business
7.5.3 Johnson&Johnson Novel Coronavirus Inactivated Vaccine Product and Services
7.5.4 Johnson&Johnson Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Johnson&Johnson Recent Developments/Updates
7.5.6 Johnson&Johnson Competitive Strengths & Weaknesses
7.6 Heat Biologics
7.6.1 Heat Biologics Details
7.6.2 Heat Biologics Major Business
7.6.3 Heat Biologics Novel Coronavirus Inactivated Vaccine Product and Services
7.6.4 Heat Biologics Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Heat Biologics Recent Developments/Updates
7.6.6 Heat Biologics Competitive Strengths & Weaknesses
7.7 Sanofi
7.7.1 Sanofi Details
7.7.2 Sanofi Major Business
7.7.3 Sanofi Novel Coronavirus Inactivated Vaccine Product and Services
7.7.4 Sanofi Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Sanofi Recent Developments/Updates
7.7.6 Sanofi Competitive Strengths & Weaknesses
7.8 Beijing Institute of Biological Products Co., Ltd
7.8.1 Beijing Institute of Biological Products Co., Ltd Details
7.8.2 Beijing Institute of Biological Products Co., Ltd Major Business
7.8.3 Beijing Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
7.8.4 Beijing Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
7.8.6 Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.9 Beijing Kexing Zhongwei Biotechnology Co., Ltd
7.9.1 Beijing Kexing Zhongwei Biotechnology Co., Ltd Details
7.9.2 Beijing Kexing Zhongwei Biotechnology Co., Ltd Major Business
7.9.3 Beijing Kexing Zhongwei Biotechnology Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
7.9.4 Beijing Kexing Zhongwei Biotechnology Co., Ltd Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Beijing Kexing Zhongwei Biotechnology Co., Ltd Recent Developments/Updates
7.9.6 Beijing Kexing Zhongwei Biotechnology Co., Ltd Competitive Strengths & Weaknesses
7.10 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd
7.10.1 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Details
7.10.2 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Major Business
7.10.3 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
7.10.4 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Recent Developments/Updates
7.10.6 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.11 Wuhan Institute of Biological Products Co., Ltd
7.11.1 Wuhan Institute of Biological Products Co., Ltd Details
7.11.2 Wuhan Institute of Biological Products Co., Ltd Major Business
7.11.3 Wuhan Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
7.11.4 Wuhan Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Wuhan Institute of Biological Products Co., Ltd Recent Developments/Updates
7.11.6 Wuhan Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Novel Coronavirus Inactivated Vaccine and Key Manufacturers
8.2 Novel Coronavirus Inactivated Vaccine Manufacturing Costs
8.3 Novel Coronavirus Inactivated Vaccine Production Process
8.4 Novel Coronavirus Inactivated Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Novel Coronavirus Inactivated Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Novel Coronavirus Inactivated Vaccine Typical Distributors
9.3 Novel Coronavirus Inactivated Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Novel Coronavirus Inactivated Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Novel Coronavirus Inactivated Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Novel Coronavirus Inactivated Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Novel Coronavirus Inactivated Vaccine Production by Region (2017-2022) & (K Units)
Table 7. World Novel Coronavirus Inactivated Vaccine Production by Region (2023-2028) & (K Units)
Table 8. World Novel Coronavirus Inactivated Vaccine Production Market Share by Region (2017-2022)
Table 9. World Novel Coronavirus Inactivated Vaccine Production Market Share by Region (2023-2028)
Table 10. World Novel Coronavirus Inactivated Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Novel Coronavirus Inactivated Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Novel Coronavirus Inactivated Vaccine Major Market Trends
Table 13. World Novel Coronavirus Inactivated Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Novel Coronavirus Inactivated Vaccine Consumption by Region (2017-2022) & (K Units)
Table 15. World Novel Coronavirus Inactivated Vaccine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Novel Coronavirus Inactivated Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Novel Coronavirus Inactivated Vaccine Producers in 2021
Table 18. World Novel Coronavirus Inactivated Vaccine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Novel Coronavirus Inactivated Vaccine Producers in 2021
Table 20. World Novel Coronavirus Inactivated Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Novel Coronavirus Inactivated Vaccine Company Evaluation Quadrant
Table 22. World Novel Coronavirus Inactivated Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Novel Coronavirus Inactivated Vaccine Production Site of Key Manufacturer
Table 24. Novel Coronavirus Inactivated Vaccine Market: Company Product Type Footprint
Table 25. Novel Coronavirus Inactivated Vaccine Market: Company Product Application Footprint
Table 26. Novel Coronavirus Inactivated Vaccine Competitive Factors
Table 27. Novel Coronavirus Inactivated Vaccine New Entrant and Capacity Expansion Plans
Table 28. Novel Coronavirus Inactivated Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Novel Coronavirus Inactivated Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Novel Coronavirus Inactivated Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Novel Coronavirus Inactivated Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Novel Coronavirus Inactivated Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Novel Coronavirus Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Novel Coronavirus Inactivated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Novel Coronavirus Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Novel Coronavirus Inactivated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Novel Coronavirus Inactivated Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Novel Coronavirus Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Novel Coronavirus Inactivated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Novel Coronavirus Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Novel Coronavirus Inactivated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Novel Coronavirus Inactivated Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Novel Coronavirus Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Novel Coronavirus Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Novel Coronavirus Inactivated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Novel Coronavirus Inactivated Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Novel Coronavirus Inactivated Vaccine Production by Type (2017-2022) & (K Units)
Table 49. World Novel Coronavirus Inactivated Vaccine Production by Type (2023-2028) & (K Units)
Table 50. World Novel Coronavirus Inactivated Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Novel Coronavirus Inactivated Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Novel Coronavirus Inactivated Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Novel Coronavirus Inactivated Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Novel Coronavirus Inactivated Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Novel Coronavirus Inactivated Vaccine Production by Application (2017-2022) & (K Units)
Table 56. World Novel Coronavirus Inactivated Vaccine Production by Application (2023-2028) & (K Units)
Table 57. World Novel Coronavirus Inactivated Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Novel Coronavirus Inactivated Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Novel Coronavirus Inactivated Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Novel Coronavirus Inactivated Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Inovio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Inovio Pharmaceuticals Major Business
Table 63. Inovio Pharmaceuticals Novel Coronavirus Inactivated Vaccine Product and Services
Table 64. Inovio Pharmaceuticals Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Inovio Pharmaceuticals Recent Developments/Updates
Table 66. Inovio Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Moderna Basic Information, Manufacturing Base and Competitors
Table 68. Moderna Major Business
Table 69. Moderna Novel Coronavirus Inactivated Vaccine Product and Services
Table 70. Moderna Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Moderna Recent Developments/Updates
Table 72. Moderna Competitive Strengths & Weaknesses
Table 73. GlaxoSmithKine Basic Information, Manufacturing Base and Competitors
Table 74. GlaxoSmithKine Major Business
Table 75. GlaxoSmithKine Novel Coronavirus Inactivated Vaccine Product and Services
Table 76. GlaxoSmithKine Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. GlaxoSmithKine Recent Developments/Updates
Table 78. GlaxoSmithKine Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer Novel Coronavirus Inactivated Vaccine Product and Services
Table 82. Pfizer Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Johnson&Johnson Basic Information, Manufacturing Base and Competitors
Table 86. Johnson&Johnson Major Business
Table 87. Johnson&Johnson Novel Coronavirus Inactivated Vaccine Product and Services
Table 88. Johnson&Johnson Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Johnson&Johnson Recent Developments/Updates
Table 90. Johnson&Johnson Competitive Strengths & Weaknesses
Table 91. Heat Biologics Basic Information, Manufacturing Base and Competitors
Table 92. Heat Biologics Major Business
Table 93. Heat Biologics Novel Coronavirus Inactivated Vaccine Product and Services
Table 94. Heat Biologics Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Heat Biologics Recent Developments/Updates
Table 96. Heat Biologics Competitive Strengths & Weaknesses
Table 97. Sanofi Basic Information, Manufacturing Base and Competitors
Table 98. Sanofi Major Business
Table 99. Sanofi Novel Coronavirus Inactivated Vaccine Product and Services
Table 100. Sanofi Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Sanofi Recent Developments/Updates
Table 102. Sanofi Competitive Strengths & Weaknesses
Table 103. Beijing Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Beijing Institute of Biological Products Co., Ltd Major Business
Table 105. Beijing Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
Table 106. Beijing Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 108. Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 109. Beijing Kexing Zhongwei Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Beijing Kexing Zhongwei Biotechnology Co., Ltd Major Business
Table 111. Beijing Kexing Zhongwei Biotechnology Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
Table 112. Beijing Kexing Zhongwei Biotechnology Co., Ltd Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Beijing Kexing Zhongwei Biotechnology Co., Ltd Recent Developments/Updates
Table 114. Beijing Kexing Zhongwei Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 115. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Major Business
Table 117. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
Table 118. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 120. Wuhan Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 121. Wuhan Institute of Biological Products Co., Ltd Major Business
Table 122. Wuhan Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
Table 123. Wuhan Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 124. Novel Coronavirus Inactivated Vaccine Raw Material
Table 125. Key Manufacturers of Novel Coronavirus Inactivated Vaccine Raw Materials
Table 126. Novel Coronavirus Inactivated Vaccine Typical Distributors
Table 127. Novel Coronavirus Inactivated Vaccine Typical Customers
Table 1. World Novel Coronavirus Inactivated Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Novel Coronavirus Inactivated Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Novel Coronavirus Inactivated Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Novel Coronavirus Inactivated Vaccine Production by Region (2017-2022) & (K Units)
Table 7. World Novel Coronavirus Inactivated Vaccine Production by Region (2023-2028) & (K Units)
Table 8. World Novel Coronavirus Inactivated Vaccine Production Market Share by Region (2017-2022)
Table 9. World Novel Coronavirus Inactivated Vaccine Production Market Share by Region (2023-2028)
Table 10. World Novel Coronavirus Inactivated Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Novel Coronavirus Inactivated Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Novel Coronavirus Inactivated Vaccine Major Market Trends
Table 13. World Novel Coronavirus Inactivated Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Novel Coronavirus Inactivated Vaccine Consumption by Region (2017-2022) & (K Units)
Table 15. World Novel Coronavirus Inactivated Vaccine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Novel Coronavirus Inactivated Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Novel Coronavirus Inactivated Vaccine Producers in 2021
Table 18. World Novel Coronavirus Inactivated Vaccine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Novel Coronavirus Inactivated Vaccine Producers in 2021
Table 20. World Novel Coronavirus Inactivated Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Novel Coronavirus Inactivated Vaccine Company Evaluation Quadrant
Table 22. World Novel Coronavirus Inactivated Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Novel Coronavirus Inactivated Vaccine Production Site of Key Manufacturer
Table 24. Novel Coronavirus Inactivated Vaccine Market: Company Product Type Footprint
Table 25. Novel Coronavirus Inactivated Vaccine Market: Company Product Application Footprint
Table 26. Novel Coronavirus Inactivated Vaccine Competitive Factors
Table 27. Novel Coronavirus Inactivated Vaccine New Entrant and Capacity Expansion Plans
Table 28. Novel Coronavirus Inactivated Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Novel Coronavirus Inactivated Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Novel Coronavirus Inactivated Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Novel Coronavirus Inactivated Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Novel Coronavirus Inactivated Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Novel Coronavirus Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Novel Coronavirus Inactivated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Novel Coronavirus Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Novel Coronavirus Inactivated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Novel Coronavirus Inactivated Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Novel Coronavirus Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Novel Coronavirus Inactivated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Novel Coronavirus Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Novel Coronavirus Inactivated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Novel Coronavirus Inactivated Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Novel Coronavirus Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Novel Coronavirus Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Novel Coronavirus Inactivated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Novel Coronavirus Inactivated Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Novel Coronavirus Inactivated Vaccine Production by Type (2017-2022) & (K Units)
Table 49. World Novel Coronavirus Inactivated Vaccine Production by Type (2023-2028) & (K Units)
Table 50. World Novel Coronavirus Inactivated Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Novel Coronavirus Inactivated Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Novel Coronavirus Inactivated Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Novel Coronavirus Inactivated Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Novel Coronavirus Inactivated Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Novel Coronavirus Inactivated Vaccine Production by Application (2017-2022) & (K Units)
Table 56. World Novel Coronavirus Inactivated Vaccine Production by Application (2023-2028) & (K Units)
Table 57. World Novel Coronavirus Inactivated Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Novel Coronavirus Inactivated Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Novel Coronavirus Inactivated Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Novel Coronavirus Inactivated Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Inovio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Inovio Pharmaceuticals Major Business
Table 63. Inovio Pharmaceuticals Novel Coronavirus Inactivated Vaccine Product and Services
Table 64. Inovio Pharmaceuticals Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Inovio Pharmaceuticals Recent Developments/Updates
Table 66. Inovio Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Moderna Basic Information, Manufacturing Base and Competitors
Table 68. Moderna Major Business
Table 69. Moderna Novel Coronavirus Inactivated Vaccine Product and Services
Table 70. Moderna Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Moderna Recent Developments/Updates
Table 72. Moderna Competitive Strengths & Weaknesses
Table 73. GlaxoSmithKine Basic Information, Manufacturing Base and Competitors
Table 74. GlaxoSmithKine Major Business
Table 75. GlaxoSmithKine Novel Coronavirus Inactivated Vaccine Product and Services
Table 76. GlaxoSmithKine Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. GlaxoSmithKine Recent Developments/Updates
Table 78. GlaxoSmithKine Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer Novel Coronavirus Inactivated Vaccine Product and Services
Table 82. Pfizer Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Johnson&Johnson Basic Information, Manufacturing Base and Competitors
Table 86. Johnson&Johnson Major Business
Table 87. Johnson&Johnson Novel Coronavirus Inactivated Vaccine Product and Services
Table 88. Johnson&Johnson Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Johnson&Johnson Recent Developments/Updates
Table 90. Johnson&Johnson Competitive Strengths & Weaknesses
Table 91. Heat Biologics Basic Information, Manufacturing Base and Competitors
Table 92. Heat Biologics Major Business
Table 93. Heat Biologics Novel Coronavirus Inactivated Vaccine Product and Services
Table 94. Heat Biologics Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Heat Biologics Recent Developments/Updates
Table 96. Heat Biologics Competitive Strengths & Weaknesses
Table 97. Sanofi Basic Information, Manufacturing Base and Competitors
Table 98. Sanofi Major Business
Table 99. Sanofi Novel Coronavirus Inactivated Vaccine Product and Services
Table 100. Sanofi Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Sanofi Recent Developments/Updates
Table 102. Sanofi Competitive Strengths & Weaknesses
Table 103. Beijing Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Beijing Institute of Biological Products Co., Ltd Major Business
Table 105. Beijing Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
Table 106. Beijing Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 108. Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 109. Beijing Kexing Zhongwei Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Beijing Kexing Zhongwei Biotechnology Co., Ltd Major Business
Table 111. Beijing Kexing Zhongwei Biotechnology Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
Table 112. Beijing Kexing Zhongwei Biotechnology Co., Ltd Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Beijing Kexing Zhongwei Biotechnology Co., Ltd Recent Developments/Updates
Table 114. Beijing Kexing Zhongwei Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 115. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Major Business
Table 117. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
Table 118. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 120. Wuhan Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 121. Wuhan Institute of Biological Products Co., Ltd Major Business
Table 122. Wuhan Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Product and Services
Table 123. Wuhan Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 124. Novel Coronavirus Inactivated Vaccine Raw Material
Table 125. Key Manufacturers of Novel Coronavirus Inactivated Vaccine Raw Materials
Table 126. Novel Coronavirus Inactivated Vaccine Typical Distributors
Table 127. Novel Coronavirus Inactivated Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Novel Coronavirus Inactivated Vaccine Picture
Figure 2. World Novel Coronavirus Inactivated Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Novel Coronavirus Inactivated Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Novel Coronavirus Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 5. World Novel Coronavirus Inactivated Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Novel Coronavirus Inactivated Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Novel Coronavirus Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 9. Europe Novel Coronavirus Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 10. China Novel Coronavirus Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 11. Japan Novel Coronavirus Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 12. Novel Coronavirus Inactivated Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Novel Coronavirus Inactivated Vaccine Demand (2017-2028) & (K Units)
Figure 15. World Novel Coronavirus Inactivated Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Novel Coronavirus Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 17. China Novel Coronavirus Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 18. Europe Novel Coronavirus Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 19. Japan Novel Coronavirus Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Novel Coronavirus Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Novel Coronavirus Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 22. India Novel Coronavirus Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Novel Coronavirus Inactivated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Novel Coronavirus Inactivated Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Novel Coronavirus Inactivated Vaccine Markets in 2021
Figure 26. United States VS China: Novel Coronavirus Inactivated Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Novel Coronavirus Inactivated Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Novel Coronavirus Inactivated Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Novel Coronavirus Inactivated Vaccine in United States
Figure 30. Key Producers and Market Share of Novel Coronavirus Inactivated Vaccine in China
Figure 31. Key Producers and Market Share of Novel Coronavirus Inactivated Vaccine in Rest of World
Figure 32. World Novel Coronavirus Inactivated Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Type in 2021
Figure 34. Adult
Figure 35. Child
Figure 36. World Novel Coronavirus Inactivated Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Novel Coronavirus Inactivated Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Novel Coronavirus Inactivated Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Novel Coronavirus Inactivated Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Novel Coronavirus Inactivated Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Novel Coronavirus Inactivated Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Novel Coronavirus Inactivated Vaccine
Figure 48. Novel Coronavirus Inactivated Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Novel Coronavirus Inactivated Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Novel Coronavirus Inactivated Vaccine Picture
Figure 2. World Novel Coronavirus Inactivated Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Novel Coronavirus Inactivated Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Novel Coronavirus Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 5. World Novel Coronavirus Inactivated Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Novel Coronavirus Inactivated Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Novel Coronavirus Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 9. Europe Novel Coronavirus Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 10. China Novel Coronavirus Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 11. Japan Novel Coronavirus Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 12. Novel Coronavirus Inactivated Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Novel Coronavirus Inactivated Vaccine Demand (2017-2028) & (K Units)
Figure 15. World Novel Coronavirus Inactivated Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Novel Coronavirus Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 17. China Novel Coronavirus Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 18. Europe Novel Coronavirus Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 19. Japan Novel Coronavirus Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Novel Coronavirus Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Novel Coronavirus Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 22. India Novel Coronavirus Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Novel Coronavirus Inactivated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Novel Coronavirus Inactivated Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Novel Coronavirus Inactivated Vaccine Markets in 2021
Figure 26. United States VS China: Novel Coronavirus Inactivated Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Novel Coronavirus Inactivated Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Novel Coronavirus Inactivated Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Novel Coronavirus Inactivated Vaccine in United States
Figure 30. Key Producers and Market Share of Novel Coronavirus Inactivated Vaccine in China
Figure 31. Key Producers and Market Share of Novel Coronavirus Inactivated Vaccine in Rest of World
Figure 32. World Novel Coronavirus Inactivated Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Type in 2021
Figure 34. Adult
Figure 35. Child
Figure 36. World Novel Coronavirus Inactivated Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Novel Coronavirus Inactivated Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Novel Coronavirus Inactivated Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Novel Coronavirus Inactivated Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Novel Coronavirus Inactivated Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Novel Coronavirus Inactivated Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Novel Coronavirus Inactivated Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Novel Coronavirus Inactivated Vaccine
Figure 48. Novel Coronavirus Inactivated Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Novel Coronavirus Inactivated Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
